Dustin Hines

Associate Professor, Department of Psychology
Expertise: Neuroscience, Human behavior, Nervous system, Alzheimer's disease, Traumatic brain injury, Stroke, Molecular genetics, Biochemistry

Biography

Dustin Hines is an associate professor of neuroscience in ÐÔÊӽ紫ý's psychology department. His expertise focuses on understanding brain function, how its cells interact to influence behavior, and supportive mechanisms within the central and peripheral nervous systems.

Hines is a co-director of the Hines Group Comprehensive Neuroscience Lab, which has pioneered the study of non-neuronal cells, known as glial cells, in the processing of information for behavioral output. His research has examined the role that glial cells play under normal and abnormal conditions, which include neuropsychiatric disorders (such as depression and PTSD), traumatic brain injury, stroke, and Alzheimer's disease. Other studies have investigated the roles of astrocytes in complex behaviors such as cognition and attention, as well as in sleep disorders and other conditions. Most recently, the lab has delved into the possible medical benefits of psychedelics.

In addition to research and teaching, Hines mentors and oversees research by high school, undergraduate, graduate, and postdoctoral students. In 2021, his lab received funding from the National Institutes of Health for an initiative to improve collaborative biomedical research efforts in the American West. 

Education

  • Postdoctoral Fellowship, Tufts University School of Medicine
  • Ph.D., Neuroscience, University of British Columbia

Dustin Hines In The News

Epoch Times
Many people don't think twice when their doctor prescribes antidepressants or other medications, but new research suggests that some of these drugs may subtly interfere with brain development in unborn babies, raising urgent questions about their safety during pregnancy.
Las Vegas Sun
In 2018, after 23 years as a Navy SEAL, Jon Dalton retired and turned his attention to a new struggle: living with depression and anxiety.
K.V.V.U. T.V. Fox 5
For decades, the federal government considered marijuana as dangerous a drug as heroin. That changed Thursday when the acting U.S. Attorney General Todd Blanchard signed an order reclassifying state-licensed cannabis products from schedule I to a far less regulated schedule III. The order does not legalize marijuana for medical or recreational use under federal law, but it does ease some barriers to cannabis research. And that came as very good news for a pair of ÐÔÊӽ紫ý scientists.
Tom's Guide
What's the first thing you did today? You may have hit the gym, made a nutritious breakfast, or rushed out the door to work, but I bet my bottom dollar that it was preceded by a five minute scroll on your phone — am I right?

Articles Featuring Dustin Hines